RSKD insider plans sale of 180,000 shares

Aglika Dotcheva filed a notice to sell up to 180,000 shares of common stock of RSKD through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $948,600.00, to be sold on the NYSE on or after 08/12/2026.

Rhea-AI Filing Summary

Aglika Dotcheva filed a notice to sell up to 180,000 shares of common stock of RSKD through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $948,600.00, to be sold on the NYSE on or after 08/12/2026.

The shares relate to 160,000 from previously exercised stock options dated 12/08/2023 and 20,000 from restricted stock units dated 07/01/2023. Dotcheva also reported multiple recent Rule 10b5-1 sales of common stock between May and July 2026, including 20,000 shares on 07/01/2026 for $100,270.00 and 19,200 shares on 07/06/2026 for $99,928.32.

Key Figures

Planned shares to be sold: 180000 shares Aggregate market value: $948,600.00 Previously exercised stock options shares: 160000 shares +5 more

8 metrics

Planned shares to be sold 180000 shares Common stock covered by the Form 144 notice

Aggregate market value $948,600.00 Value of 180,000 common shares planned for sale

Previously exercised stock options shares 160000 shares Shares from stock options dated 12/08/2023

Restricted Stock Units shares 20000 shares Shares from RSUs dated 07/01/2023

10b5-1 sale 07/06/2026 19200 shares; $99,928.32 Common shares sold under Rule 10b5-1 plan

10b5-1 sale 07/01/2026 20000 shares; $100,270.00 Common shares sold under Rule 10b5-1 plan

10b5-1 sale 06/01/2026 19600 shares; $98,039.20 Common shares sold under Rule 10b5-1 plan

10b5-1 sale 05/19/2026 400 shares; $2,000.00 Common shares sold under Rule 10b5-1 plan

Key Terms

Previously Exercised Stock Options, Restricted Stock Units, 10b5-1 Sales, Executive Financial Services

4 terms

Previously Exercised Stock Options financial

"Common | 12/08/2023 | Previously Exercised Stock Options | issuer"

Restricted Stock Units financial

"Common | 07/01/2023 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 Sales regulatory

"10b5-1 Sales for AGLIKA DOTCHEVA 220 5th Avenue"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the RSKD Form 144 filing by Aglika Dotcheva disclose?

The filing discloses a planned sale of up to 180,000 common shares of RSKD, valued at $948,600.00, to be sold through Morgan Stanley Smith Barney LLC on or after 08/12/2026 on the NYSE.

How many RSKD shares are tied to options and RSUs in this Form 144?

The notice ties 160,000 shares to previously exercised stock options dated 12/08/2023 and 20,000 shares to restricted stock units dated 07/01/2023, together forming the 180,000 shares covered.

What recent 10b5-1 stock sales by Aglika Dotcheva in RSKD are reported?

Reported Rule 10b5-1 sales include 20,000 shares on 07/01/2026 for $100,270.00 and 19,200 shares on 07/06/2026 for $99,928.32, among several trades between May and July 2026.

Which broker is handling the planned RSKD share sale for Aglika Dotcheva?

The planned sale of up to 180,000 common shares of RSKD is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004.

On which exchange are Aglika Dotcheva’s planned RSKD sales expected to occur?

The Form 144 indicates the NYSE as the exchange for the planned sale of up to 180,000 common shares of RSKD with an aggregate market value of $948,600.00.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/12/2026 - 04:33 PM Accepted by SEC EDGAR 08/12/2026 - 04:33 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001955807
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RISKIFIED LTD
SEC File Number	001-40692
Address of Issuer	220 5th Avenue, 2nd Floor New York NEW YORK 10001
Phone	2033009264
Name of Person for Whose Account the Securities are To Be Sold	AGLIKA DOTCHEVA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	180000	948600.00	104034048	08/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/08/2023	Previously Exercised Stock Options	issuer			160000	12/08/2023	Cash
Common	07/01/2023	Restricted Stock Units	Issuer			20000	07/01/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for AGLIKA DOTCHEVA 220 5th Avenue, 2nd Floor New York NY 10001	Common	07/06/2026	19200	99928.32
10b5-1 Sales for AGLIKA DOTCHEVA 220 5th Avenue, 2nd Floor New York NY 10001	Common	07/02/2026	800	4160.00
10b5-1 Sales for AGLIKA DOTCHEVA 220 5th Avenue, 2nd Floor New York NY 10001	Common	07/01/2026	20000	100270.00
10b5-1 Sales for AGLIKA DOTCHEVA 220 5th Avenue, 2nd Floor New York NY 10001	Common	06/01/2026	19600	98039.20
10b5-1 Sales for AGLIKA DOTCHEVA 220 5th Avenue, 2nd Floor New York NY 10001	Common	05/19/2026	400	2000.00

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 7/1/2023 through 10/1/2024
Date of Notice	08/12/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/15/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Aglika Dotcheva
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)